CELMED ONCOLOGY USA INC has a total of 27 patent applications. Its first patent ever was published in 1998. It filed its patents most often in United States, Australia and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and micro-structure and nano-technology are BIPAR SCIENCES INC, INTERNAT MEDICAL INNOVATIONS I and AEROMICS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 11 | |
#2 | Australia | 4 | |
#3 | EPO (European Patent Office) | 4 | |
#4 | Brazil | 2 | |
#5 | Canada | 2 | |
#6 | China | 1 | |
#7 | Israel | 1 | |
#8 | Mexico | 1 | |
#9 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Micro-structure and nano-technology | |
#4 | Biotechnology | |
#5 | Measurement | |
#6 | Environmental technology | |
#7 | Foods and drinks |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Nanostructure applications | |
#4 | Measuring microorganism processes | |
#5 | Special acyclic compounds | |
#6 | Sugars | |
#7 | Analysing materials | |
#8 | Climate change adaptation technologies | |
#9 | Peptides | |
#10 | Enzymes |
# | Name | Total Patents |
---|---|---|
#1 | Sergeeva Maria V | 12 |
#2 | Doppalapudi Venkata Ramana | 12 |
#3 | Shepard H Michael | 9 |
#4 | Ballatore Carlo | 5 |
#5 | Groziak Michael P | 3 |
#6 | Chan Ming Fai | 2 |
#7 | Vaino Andrew Rein | 2 |
#8 | Lehsten Danielle M | 2 |
#9 | Shepard H M | 2 |
#10 | Shepard Michael H | 1 |
Publication | Filing date | Title |
---|---|---|
US2007155673A1 | Use of bvdu for inhibiting the growth of hyperproliferative cells | |
US7001922B2 | Peptide deformylase activated prodrugs | |
WO03088913A2 | Peptide deformylase activated prodrugs | |
US7462605B2 | Phosphoramidate compounds and methods of use | |
AU2002241911A1 | Methods to treat autoimmune and inflammatory conditions | |
EP1240922A2 | Methods and compositions for overcoming resistance to biologic and chemotherapy |